GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms ...

GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk: London, UK Tuesday, May 19, 2026, 12:00 Hrs [IST] GSK plc announced tha ...

Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The pulmonary arterial hypertension clinical trial ...

Patients with severe asthma who are typically underrepresented in clinical studies experienced improved outcomes with ...

President Donald Trump’s drug-pricing platform TrumpRx is expanding to offer 600 generic medications — and partner with ...

Cohere Inc. says it has acquired a data analytics platform operating in the biopharma sector. The Canadian artificial ...

Deal is second such transaction for Toronto-based Cohere this year after announcing merger with German AI company Aleph Alpha ...

Cohere, the world’s leading sovereign AI company, announced today the acquisition of Reliant AI, a leading biopharma AI company with operations in Montreal and Berlin. This acquisition brings Reliant ...

More than 100,000 previously unreached children have now been identified and vaccinated under a targeted campaign aimed at reducing the growing burden of zero dose children in Lagos State.The campaign ...

Alector’s updated analyst framework now points to a fair value move from US$2.88 to US$3.10, a modest shift that still signals a meaningful recalibration of expectations. This change is closely tied ...

Visakhapatnam: In alignment with the Government of India’s initiative to reduce fuel consumption, combat global warming and ...

The FTSE 100 Index, the flagship benchmark of the London Stock Exchange and the United Kingdom's most widely recognised measure of large-cap equity performance, entered the trading week of 18 May 2026 ...